Article Text


Total serum IgE and outcome in infants with recurrent wheezing
  1. Department of Child Health, University of Aberdeen, Aberdeen AB25 2ZD, UK


    OBJECTIVE To investigate the relation between total serum IgE at 0.5–3 and 3–6 years, and the risk of allergic sensitisation and persistent wheezing up to 8 years of age.

    METHODS Prospective follow up study of 45 infants with highly recurrent wheezing, no allergic symptoms, and negative skin tests.

    RESULTS In the last follow up year, 15 children still suffered from wheezing. Five wheeze-free and four episodically wheezing children had become sensitised. No association was found between early (0.5–3 years) IgE z scores and the recurrence of wheezing during follow up, or atopic sensitisation. IgE z scores at 3–6 years were significantly higher in children with positive skin tests (p = 0.013), but were still not associated with recurrence of wheezing.

    CONCLUSIONS In subjects with frequent early wheezing and no signs of atopy, early total serum IgE measurements are not predictive of outcome.

    • IgE
    • wheezing
    • childhood asthma

    Statistics from

    A close association between total serum IgE levels and the prevalence of asthma, independent of specific reactivity to allergens, has been reported in cross sectional population studies in children and adults.1 2 A prospective population study has also shown that children with early sensitisation and persistent wheezing had high IgE levels throughout childhood.3

    The purpose of our study was to investigate the relation between total serum IgE and the risk of persistent wheezing and allergic sensitisation in a hospital based cohort of infants with highly recurrent wheezing and no signs of atopy. Although most wheezing infants outgrow their symptoms by school age, patients seen in asthma clinics have significantly worse outcomes than are found in longitudinal studies of the general population, reflecting the more severe asthma in children referred to hospital. From a practical point of view, it would therefore be useful to know if serum IgE could predict which children are at risk of more severe disease.



    Fifty eight infants, born at full term and aged between 9 months and 2 years (median age 1.6 years), who attended the asthma clinic between January 1990 and December 1991 were enrolled in the study. The inclusion criteria were a history of wheezing triggered by infections (fever and/or rhinitis); at least five wheezing attacks during the first two years of life; no history of atopic disease (eczema, urticaria, rhinoconjunctival symptoms apart from colds, shortness of breath with pollens, animals, or house dust); and negative skin tests for egg, milk, wheat, cat and dog dander, and the most common aeroallergens.


    The children were followed up prospectively until 8 years of age. Skin tests were performed once a year; serum IgE concenterations were determined twice (four weeks or more after an acute respiratory illness), between the ages of 0.5 and 3 years, and between 3 and 6 years.


    Skin prick tests were considered positive in the presence of a wheal of ⩾ 3 mm in diameter and in the absence of a reaction to the control solution. Serum IgE levels were determined using the CAP system IgE FEIA (Pharmacia, Uppsala, Sweden) and log transformed for statistical analysis. An age related IgE z score was calculated, using Kjellmann's age related values after log transformation.4


    Thirteen subjects were lost to follow up (nine because of a change of address and four because their parents refused further clinical evaluation).

    During their first 3 years of life, the 45 children studied experienced a median of 10 (range 5 to 34) wheezing episodes, which tended to decrease between the ages of 3 and 8 years (median 6; range 0 to 26). During the last follow up year, 15 children were still experiencing episodic wheezing, four of whom also had wheezing symptoms between the attacks. Sensitisation to at least one aeroallergen was observed in nine children between the ages of 5 and 8 years; five had stopped wheezing and four still experienced episodic wheezing in the last year of follow up.

    The mean (SD) IgE z score decreased significantly (p = 0.0002, pairedt test) from 2.63 (1.53) during the first 3 years of life to 2.02 (1.17) between 3 and 6 years. The mean IgE z score at 0.5–3 years was not significantly different in the children with positive or negative skin prick tests, but at 3–6 years it was higher (p = 0.013) in the children with positive skin prick tests.

    No association was found between the IgE z scores at 0.5–3 or 3–6 years and the number of wheezing episodes at 3–8 years of life (fig 1; p = 0.93 and p = 0.14), or the presence of wheezing during the last year of follow up (p = 0.90 and p = 0.21).

    Figure 1

    Number of wheezing episodes v IgE Z scores at 0.5–3 and 3–6 years of age.


    In infants with highly recurrent infection triggered wheezing, no allergic symptoms, and negative skin tests, there was no relation between early (0.5–3 years) total serum IgE and the recurrence of wheezing up to 8 years of age or allergic sensitisation. The fact that IgE levels at 3–6 years of life were higher in sensitised children is clinically irrelevant because sensitisation did not seem to be an important risk factor for wheezing; in fact five of nine sensitised children had stopped wheezing in the last year of follow up. The major determinant of asthma in these children might be a congenital impairment in airway function. In severely affected subjects chronic airway inflammation probably further maintains the disease.

    Increased total serum IgE has been observed in association with acute viral infections in both atopic and non-atopic individuals.5 Although we measured serum IgE at least four weeks after an acute infection leading to wheezing, we cannot exclude the possibility that viral exposure may have provoked an abnormal IgE response in our patients. It has also been suggested that production of IgE not driven by specific allergens could be a consequence of the inflammatory process in the asthmatic airways.6


    Our study suggests that in infants with frequent wheezing and no signs of atopy measurement of total serum IgE will not help predict which subjects are either at risk for recurrent or persistent wheezing symptoms or atopic sensitisation by school age.



    The differential diagnosis of wheeze in childhood has always been difficult, and in the past various ill defined syndromes were recognised and distinguished from asthma, including asthmatic bronchitis and wheezy bronchitis. Thus in a general practice survey conducted in 1958, Logan and Cushion1-1 reported an annual consultation rate for asthma of 0.9% of children, with a male to female ratio of 2:1, compared with consultation rates for bronchitis of 6.9% of children, in whom the sex ratio was 1.1:1. These sex differences suggested that bronchitis and asthma might be different disorders, but in an influential paper from Melbourne, Howard Williams and his colleagues concluded that, at least epidemiologically, wheezy bronchitis could not be distinguished from asthma.1-2Following the publication of this paper, it gradually became established practice to diagnose asthma in the great majority of children with recurrent wheeze, and at least some of the recent increase in asthma has been the result of such changes in diagnostic labelling.1-3 1-4

    Diagnostic lumping is of course easier than splitting, especially in the absence of satisfactory definitions to permit accurate splitting, and has the potential advantage of ensuring that underdiagnosis is not followed by undertreatment.1-5 However, it soon became apparent that in early childhood lumping was creating new problems. Many patients were receiving inappropriate (and ineffective1-6) asthma treatment for virus associated wheeze, a transient problem that is generally gone by school age. Calls for a change in terminology1-7 have not so far borne much fruit, although there has been some transatlantic support for revisiting the traditional diagnosis of wheezy bronchitis.1-8

    It is difficult to make a firm diagnosis in children who wheeze in association with upper respiratory tract infection. If asthma is defined as reversible airways obstruction, then those children who wheeze with infection and are apparently normal between attacks fit this bill. On the other hand, if asthma is defined as allergic airways disease, then few such children have any evidence of allergy and would not be considered to be asthmatic. The situation is further confused by the fact that upper respiratory tract infection is the most important trigger for wheeze in children with asthma.1-9 Nevertheless, the case for distinguishing virus associated wheeze from asthma is becoming increasingly strong.

    In a group of children who had been admitted to hospital before the age of 2 years with an acute wheezing episode, and followed up to around the age of 5 years, Wilson et alfound that bronchial responsiveness and illness severity were related to a family history of asthma but not to the results of skin prick testing or serum IgE.1-10 In other words, early onset wheeze appeared to be a different condition from classical atopic asthma. The mechanism of vims associated wheeze is uncertain, but may reflect a congenital diminution of airway size.1-11 What is increasingly clear is that virus associated wheeze is not a precursor of asthma in later childhood.1-12

    Rusconi et al's paper describes 45 children with recurrent wheeze associated with infections in the first 2 years of life who were followed until the age of 8 years. The wheeze tended to diminish (and in two thirds it disappeared) during the follow up period, and the course of the illness was unrelated to IgE concentration either at 0.5 to 3 years of age, or at 3 to 6 years. These findings add further support to the view that virus associated wheeze in early childhood is not related to atopy.

    Perhaps it is time for a change of name.1-7


    1. 1-1.
    2. 1-2.
    3. 1-3.
    4. 1-4.
    5. 1-5.
    6. 1-6.
    7. 1-7.
    8. 1-8.
    9. 1-9.
    10. 1-10.
    11. 1-11.
    12. 1-12.
    View Abstract

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.